Quinn Opportunity Partners’s Repare Therapeutics RPTX Stock Holding History

Quinn Opportunity Partners’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$104K	–	407
2025 Q4	$104K	Hold	40,000	–	–	﹤0.01%	353
2025 Q3	$70.4K	Hold	40,000	–	–	0.01%	317
2025 Q2	$55.6K	Buy	+40,000	New	+$52.2K	﹤0.01%	340

Quinn Opportunity Partners's RPTX Position: Q1 2026 in Review

Quinn Opportunity Partners sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 40,000 shares — an estimated $104K sold.

Quinn Opportunity Partners first reported a position in RPTX in Q2 2025 and held it in 3 quarters. The position peaked at $104K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Quinn Opportunity Partners reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Quinn Opportunity Partners sold 40,000 Repare Therapeutics shares in Q1 2026, an estimated $104K.
Quinn Opportunity Partners first reported a position in Repare Therapeutics in Q2 2025 and held it in 3 quarters.
Quinn Opportunity Partners's Repare Therapeutics position peaked at $104K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.